Precision Medicine Based on Precision Science

MindX Therapeutics is committed to addressing brain health disorders and pain. We develop safe, inexpensive and innovative combination medicines through repurposing, using our targeted, biomarker-informed approach.

Our First Product

MXT-333 is a metabolic psychiatry add-on combination medicine for use in treatment-resistant depression, as well as in depression and stress disorders more broadly. It targets adrenergic, serotonergic, and inflammatory mechanisms.

The Future

Our products will help with the prevention of psychiatric disease episodes and pain in people with a family history or previous personal history.

Precision Drug Development by Leveraging RNA Biomarkers

Through MindX Sciences technology, MindX Therapeutics is repurposing medications for some of the most critical mental health conditions while also identifying new medications with higher efficacy and fewer side effects compared to existing medications

Learn More about MindX Sciences
MindX Therapeutics Programs
MindX Therapeutics Programs